3. Jordan Schneider and Tanner Greer dialog over China, Taiwan, etc., recommended, two EV winners by the way.
5. WSJ covers monoclonal antibody treatments, one focus of Fast Grants I might add. They work (mostly), albeit with significant issues of scaling and distribution. Some of the drugs might be available by the fourth quarter, if they clear testing.